Correction to Lancet Infect Dis 2021; 21: 1257–70

Goepfert PA, Fu B, Chabanon A-L, et al. Safety and immunogenicity of SARS-CoV-2 recombinant protein vaccine formulations in healthy adults: interim results of a randomised, placebo-controlled, phase 1–2, dose-ranging study. Lancet Infect Dis 2021; 21: 1257–70—In figure 4 of this Article, the diamond and triangle symbols were inverted in the key; the diamond represents high dose and the triangle represents placebo. Additionally, in panel B of figure 4 (for participants aged 18–49 years), the placebo datapoints were omitted. These corrections have been made to the online version as of June 10, 2022.